Cargando…

17-Hydroxyprogesterone Response to Standard Dose Synacthen Stimulation Test in CYP21A2 Heterozygous Carriers and Non-carriers in Symptomatic and Asymptomatic Groups: Meta-analyses

OBJECTIVE: Standard dose synacthen stimulation test (SDSST) is a gold standard screening test for evaluating adrenal gland function. Despite studies using SDSST to identify heterozygosity in CYP21A2, the reliability of the test for this purpose is still controversial. Therefore, the meta-analyses we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polat, Seher, Arslan, Yusuf Kemal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900072/ https://www.ncbi.nlm.nih.gov/pubmed/34743977 http://dx.doi.org/10.4274/jcrpe.galenos.2021.2021.0184

Ejemplares similares

Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, non-carriers, and females with non-classic congenital hyperplasia
por: Silva, Rita Santos, et al.
Publicado: (2022)

Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation
por: Baert, Annelot, et al.
Publicado: (2016)

First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2022)

Exome sequencing identifies novel dysferlin mutation in a family with pauci-symptomatic heterozygous carriers
por: Jalali-Sefid-Dashti, Mahjoubeh, et al.
Publicado: (2018)

High-Dose Hook Effect in 17-Hydroxyprogesterone Assay in a Patient with 21-Hydroxylase Deficiency
por: Parlak, Mesut, et al.
Publicado: (2015)

Clinical Characteristics of Immune Response in Asymptomatic Carriers and Symptomatic Patients With COVID-19
por: Li, Entao, et al.
Publicado: (2022)

Performance of synacthen test in chronic hemodialysis patients
por: Nickler, Manuela, et al.
Publicado: (2023)

Mild dopa-responsive dystonia in heterozygous tyrosine hydroxylase mutation carrier: Evidence of symptomatic enzyme deficiency?
por: Bally, Julien F., et al.
Publicado: (2020)

Heterozygous Pathogenic and Likely Pathogenic Symptomatic HTRA1 Variant Carriers in Cerebral Small Vessel Disease
por: Xu, Sui-Yi, et al.
Publicado: (2023)

Molecular analysis of hepatitis B virus "a" determinant in asymptomatic and symptomatic Mexican carriers
por: Ruiz-Tachiquín, Martha-Eugenia, et al.
Publicado: (2007)

The short synacthen test: Variations in methodology and protocols in KSA
por: Butt, Muhammad I., et al.
Publicado: (2022)

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2020)

Clinical and neurophysiological characteristics of heterozygous NPC1 carriers
por: Benussi, Alberto, et al.
Publicado: (2019)

Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers
por: Migueres, Marion, et al.
Publicado: (2020)

Management of the asymptomatic BRCA mutation carrier
por: Teller, Paige, et al.
Publicado: (2010)

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011)

An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
por: Teti, Claudia, et al.
Publicado: (2023)

Clinical and laboratory test in patients with familial amyloid polyneuropathy: differences between symptomatic patients and asymptomatic carriers
por: Raya-Cruz, Manuel, et al.
Publicado: (2015)

650. Genomic Analysis of Shiga Toxin-producing Escherichia coli From Symptomatic Patients and Asymptomatic Carriers
por: Baba, Hiroaki, et al.
Publicado: (2018)

Phenotypic Characterization of Female Carrier Mice Heterozygous for Tafazzin Deletion
por: Tomczewski, Michelle V., et al.
Publicado: (2023)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004)

CalDAG-GEFI Deficiency in a Family with Symptomatic Heterozygous and Homozygous Carriers of a Likely Pathogenic Variant in RASGRP2
por: Morais, Sara, et al.
Publicado: (2021)

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth
por: Alizadeh, Fahimeh, et al.
Publicado: (2022)

An Epidemiological Model of Malaria Accounting for Asymptomatic Carriers
por: Aguilar, Jacob B., et al.
Publicado: (2020)

At-home sample collection is an effective strategy for diagnosis and management of symptomatic and asymptomatic SARS-CoV-2 carriers
por: Humphreys, Devon P., et al.
Publicado: (2022)

Microbiome Profiling of Enterotoxigenic Escherichia coli (ETEC) Carriers Highlights Signature Differences between Symptomatic and Asymptomatic Individuals
por: Higginson, Ellen E., et al.
Publicado: (2022)

Synacthen Stimulation Test Following Unilateral Adrenalectomy Needs to Be Interpreted With Caution
por: Zaman, Shamaila, et al.
Publicado: (2021)

HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity
por: Penttinen, Kirsi, et al.
Publicado: (2023)

COMPARISON OF METHODS TO IDENTIFY Neisseria meningitidis IN ASYMPTOMATIC CARRIERS
por: RIZEK, Camila F., et al.
Publicado: (2016)

Implications of asymptomatic carriers for infectious disease transmission and control
por: Chisholm, Rebecca H., et al.
Publicado: (2018)

Detection of asymptomatic carriers of malaria in Kohat district of Pakistan
por: Naeem, Muhammad Abdul, et al.
Publicado: (2018)

Rates of lobar atrophy in asymptomatic MAPT mutation carriers
por: Chen, Qin, et al.
Publicado: (2019)

Asymptomatic malaria carriers and their characterization in hotpops of malaria at Mangalore
por: Ramaswamy, Akash, et al.
Publicado: (2020)

A confirmed asymptomatic carrier of 2019 novel coronavirus
por: Luo, Si-Hui, et al.
Publicado: (2020)

COVID-19: asymptomatic carrier transmission is an underestimated problem
por: Zhao, Hongjun, et al.
Publicado: (2020)

COVID-19: Asymptomatic Carrier: An Autopsy Case Report
por: Malik, Yogender, et al.
Publicado: (2021)

Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations
por: Neocleous, Vassos, et al.
Publicado: (2014)

Pulmonary hypertension may be secondary in carriers of compound heterozygous FOXRED1 variants
por: Finsterer, Josef
Publicado: (2019)

Chemotherapy in a Breast Cancer Patient Heterozygous Carrier of Ornithine Transcarbamylase Deficiency
por: Palka-Kotlowska, Magda, et al.
Publicado: (2020)

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_dca5d83dbeqfcenrmkgp0t88lp